XML 27 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common Shares Outstanding
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2021   27,714,071          
Beginning balance at Dec. 31, 2021 $ 558,267   $ 426,091 $ 98,073 $ 42,015 $ (7,960) $ 48
Increase (Decrease) in Shareholders' Equity              
Net income 73,928       73,928    
Other comprehensive income (loss) (136,024)         (136,024)  
Cash dividends declared (28,505)       (28,505)    
Common stock sold by directors' deferred compensation plan 2,041   2,041        
Common stock repurchased and other related costs (in shares)   (868,613)          
Common stock repurchased and other related costs (20,740)   (20,740)        
Share-based compensation (in shares)   179,612          
Share-based compensation expense 3,952   679 3,273      
Ending balance (in shares) at Dec. 31, 2022   27,025,070          
Ending balance at Dec. 31, 2022 452,871   408,071 101,346 87,438 (143,984) 0
Increase (Decrease) in Shareholders' Equity              
Net income 58,669       58,669    
Other comprehensive income (loss) 21,388         21,388  
Cash dividends declared (28,117)       (28,117)    
Common stock repurchased and other related costs (in shares)   (130,010)          
Common stock repurchased and other related costs (2,632)   (2,632)        
Share-based compensation (in shares)   149,973          
Share-based compensation expense $ 1,636   0 1,636      
Non-controlling interest             (48)
Ending balance (in shares) at Dec. 31, 2023 27,045,033 27,045,033          
Ending balance at Dec. 31, 2023 $ 503,815   405,439 102,982 117,990 (122,596) 0
Increase (Decrease) in Shareholders' Equity              
Net income 53,412       53,412    
Other comprehensive income (loss) 8,174         8,174  
Cash dividends declared (28,143)       (28,143)    
Common stock repurchased and other related costs (in shares)   (49,960)          
Common stock repurchased and other related costs (945)   (945)        
Share-based compensation (in shares)   70,497          
Share-based compensation expense $ 2,072   0 2,072      
Ending balance (in shares) at Dec. 31, 2024 27,065,570 27,065,570          
Ending balance at Dec. 31, 2024 $ 538,385   $ 404,494 $ 105,054 $ 143,259 $ (114,422) $ 0